Immunoinformatics-based multi-epitope containing fused polypeptide vaccine design against visceral leishmaniasis with high immunogenicity and TLR binding-Reference-Cited by-同舟云学术

Immunoinformatics-based multi-epitope containing fused polypeptide vaccine design against visceral leishmaniasis with high immunogenicity and TLR binding

Published:2023-12 Issue: Volume:253 Page:127567
ISSN:0141-8130
Container-title:International Journal of Biological Macromolecules
language:en
Short-container-title:International Journal of Biological Macromolecules

Author:

Kumar Pawan,Kumar Prakash,Shrivastava Ashish,Dar Mukhtar Ahmad,Lokhande Kiran Bharat,Singh Nidhi,Singh Ashutosh,Velayutham Ravichandiran,Mandal Debabrata

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Biochemistry,Structural Biology

Reference60 articles.

1. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?;Chappuis;Nat. Rev. Microbiol.,2007

2. Leishmaniasis in humans: drug or vaccine therapy?;Ghorbani;Drug Des. Devel. Ther.,2017

3. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019;Lancet,2020

4. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic;Sundar;Clin. Infect. Dis.,2000

5. Visceral Leishmaniasis: advancements in vaccine development via classical and molecular approaches;Joshi;Front. Immunol.,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of newer generation Vascular endothelial growth factor Receptor-2 Inhibitors: Pharmacophore based design, virtual Screening, molecular Docking, molecular dynamic Simulation, and DFT analyses;Journal of King Saud University - Science;2024-09